SPRINGWORKS THERAPEUTICS, INC. (SWTX) Social Stream



SPRINGWORKS THERAPEUTICS, INC. (SWTX): $37.45

-1.74 (-4.44%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SWTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 389

in industry

SpringWorks Therapeutics Inc (SWTX) Price Targets From Analysts

Use the tables below to see what analysts covering SpringWorks Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-05 4 $137 $92 $111.5 $56.9 95.96%
2022-02-24 4 $137 $105 $114.75 $56.9 101.67%
2022-02-25 4 $137 $101 $113.25 $56.9 99.03%
2022-03-01 5 $142 $101 $114.5 $56.9 101.23%

The Trend in the Analyst Price Target


SWTX's average price target has moved up $4.25 over the prior 44 weeks.

Over the past 46 weeks, SWTX's average upside potential has been 54.48%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-26 0 124 104 110.00 84.89 29.58%
2021-08-05 0 136 104 117.00 86.01 36.03%
2021-08-07 0 137 104 117.25 81.85 43.25%
2021-08-14 0 137 104 117.25 75.31 55.69%
2021-09-04 0 137 104 117.25 72.00 62.85%

SWTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


Over the past 120 days, SWTX's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SWTX as an investment opportunity.

  • SpringWorks Therapeutics Inc's average analyst price target is higher than 348.4% of Pharmaceutical Products stocks.
  • In terms of how SpringWorks Therapeutics Inc fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 73.21% of that group.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, SpringWorks Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 318.89% of them.
  • SpringWorks Therapeutics Inc's variance in analysts' estimates is lower than -9.21% of Pharmaceutical Products stocks.

Stocks similar to SpringWorks Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are SRNE, SGMO, and SANA.

What is the outlook for SWTX? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.9631 seconds.